510(k) K955157
K955157 is an FDA 510(k) premarket notification submitted by Alexon Biomedical, Inc. for the device "PROSPECT GIARDIA/CRYPTOSPORIDIUM MICROPLATE ASSAY". The FDA issued a decision of Substantially Equivalent on February 9, 1996. The device falls under product code MHI (Giardia Spp.), a Class II device regulated under 21 CFR 866.3220. Alexon Biomedical, Inc. has at least 4 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 9, 1996
- Date Received
- November 13, 1995
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Giardia Spp.
- Device Class
- Class II
- Regulation Number
- 866.3220
- Review Panel
- MI
- Submission Type